AML CYTOGENETICS PANEL

A comprehensive test used to assess chromosomal abnormalities in acute myeloid leukemia (AML) patients. It identifies specific genetic mutations and translocations that help predict prognosis and guide treatment. The panel is critical for evaluating treatment strategies and patient outcomes.

Also known asAml Cytogenetics Panel Aml Cytogenetics Panel

Available via

Home Collection, Lab Visit

Contains

11 parameters

Earliest reports in

10 Working Days

Test details
Preparations

No special preparations needed

Test included
AML CYTOGENETICS PANEL includes 11 parameters

  • Specimen
  • Indications
  • Cells Counted & Analysed
  • Cells Karyotyped
  • Karyotype

  • Specimen
  • Clinical Indications
  • Total Number Of Cells
  • Interpretation

  • Interpretation

  • Interpretation

Test code

7900

Specimen vol. and vacutainer information
SpecimenVacutainerVolume
Bone MarrowOthers3 ML
Bone Marrow HeparinGreen Vacutainer3 ML
Heparin Whole BloodGreen Vacutainer11 ML

Specimen stability information

Bone Marrow, Heparin Whole Blood

Collection instructions

Bone Marrow/Wb Wb (=70% Blast Cell) Sodium Heparin  Specimen To Reach Us With In 24- 48 Hrs + Clinical History In Specified Format, Blood Picture(Cbc Report) And Medication Of The Patient On The Trf In Specimen Column

Specimen rejection criteria

Test run frequency

'

Turn around time

10 Working Days

Performing locations

Department

  • Cytogenetics

CPT and Loinc codes

AML CYTOGENETICS PANEL

13100